View of Single-agent chemotherapy versus polychemotherapy in first-line treatment of advanced soft tissue sarcoma: for and against on the basis of the recent EORTC 62012 phase III trial

Return to Article Details Single-agent chemotherapy versus polychemotherapy in first-line treatment of advanced soft tissue sarcoma: for and against on the basis of the recent EORTC 62012 phase III trial Download Download PDF